Let’s be real — this letter is basically three things: 1️⃣ A reassurance PR exercise aimed at calming frustrated shareholders 2️⃣ A gentle reminder that early-stage biotech = slow pain + future gain (maybe) 3️⃣ And most of all: a polite way of saying “We’re not dead… but we’re not delivering either.”
IMU Price at posting:
2.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)